Corporate Profile

SeaStar Medical is a publicly traded medical technology company that is redefining how extracorporeal therapies can reduce the consequences of excessive inflammation on vital organs through novel solutions and services. Our focus is on transforming key immune system messengers from pro-inflammatory to reparative physiology or removing pro-inflammatory mediators, known as cytokines. The impact of inflammation on organs and long-term health is just beginning to be understood. We have studied the market, assembled the experts to research the science and evaluated the opportunity.

With a new management team, fresh focus and innovative products in development, we invite you to get to know today’s SeaStar Medical.

Special Meeting of Stockholders

Date & Time: Thursday, March 28, 2025 at 10:00 AM MDT

Link to Definitive Proxy Statement:
https://www.sec.gov/Archives/edgar/data/1831868/000121390025018763/ea0231291-02.htm

Proxy Voting by Phone: 1-866-868-2739

Link to Proxy Voting Website: www.proxypush.com/ICU

Please return a properly completed proxy card, or vote your shares by telephone or internet as follows:
• FOR the Common Warrants Proposal
• FOR the Warrant Amendment Proposal
• FOR the Adjournment Proposal

SeaStar Medical’s Board of Directors unanimously supports these proposals and recommends that you vote FOR each proposal.